Ministers could rule out legal aid for
cases of medical negligence cases
By Robert Verkaik Legal Affairs Correspondent - Independent.co.uk
21 August 2002
Patients who have been injured by medical blunders could be denied
the right to bring their claims to court under a government review of
the soaring cost of litigation against the NHS.
In a move that would save the Treasury millions of pounds each year,
ministers are exploring proposals to replace legal aid ñ which is used
in 70 per cent of negligence cases ñ with "no win, no fee" agreements
between patients and their solicitors. A letter from the Lord
Chancellor's Department to a doctor complaining about the cost of
compensation confirms that research is under way to establish where the
"burden of risk might be shifted from the public purse to private
practitioners". The NHS is facing a record £4.4bn bill in outstanding
negligence claims.
The letter says ministers are also looking at "non-financial remedies
in cases of clinical negligence". It adds: "This Department and the
Legal Services Commission are working closely with the Department of
Health to ensure a common approach to the funding of claims and to
reduce public expenditure on clinical negligence cases."
Solicitors' and patients' groups said any reduction in legal aid
would leave thousands of people without recourse to justice. Arnold
Simanowitz, the chief executive of Action for Victims of Medical
Accidents, said: "I think it would be a scandal if they removed public
funding for clinical negligence cases."
Research has shown that solicitors take conditional fee cases ñ where
they do not get paid unless they win ñ only if there is at least a 70
per cent chance of success. Mr Simanowitz said: "The conditional fee
market is not ready to handle complex medical negligence cases. Many
people would have to pay thousands of pounds to investigate their claims
before solicitors would be prepared to take them on." David Marshall of
the Association of Personal Injury Lawyers said: "This is the wrong time
to look at extending conditional fees to clinical negligence cases."
The letter acknowledges that "no win, no fee" has "often proved to be
unsuitable for complex ... clinical negligence claims" and says a
decision depends on the "maturity" of the fee market.